000228392 001__ 228392
000228392 005__ 20180318102419.0
000228392 013__ $$aEP2870175$$bEP$$cB1$$d20171220
000228392 013__ $$aEP2870175$$bEP$$cA1$$d20150513
000228392 013__ $$aCN104603148$$bCN$$cA$$d20150506
000228392 013__ $$aAU2013285470$$bAU$$cA1$$d20150129
000228392 013__ $$aCA2878100$$bCA$$cA1$$d20140109
000228392 013__ $$aUS2014010832$$bUS$$cA1$$d20140109
000228392 013__ $$aWO2014006082$$bWO$$cA1$$d20140109
000228392 02470 $$2EPO Family ID$$a48746508
000228392 02470 $$2TTO$$a6.1195
000228392 037__ $$aPATENT
000228392 245__ $$aConjugates containing sequences from placenta growth factor and their use as components of biomaterials and in medicine
000228392 260__ $$c2015
000228392 269__ $$a2015
000228392 336__ $$aPatents
000228392 520__ $$aEmbodiments of the invention are described, including materials and methods for making molecules and materials that have a specific binding domain of a P1GF2. Embodiments include, for instance, medicaments, biomaterials, biomolecules, molecular fusions, and vaccines.
000228392 700__ $$0240350$$aHubbell, Jeffrey A$$g141360
000228392 700__ $$aMartino, Mikael
000228392 700__ $$aBriquez, Priscilla Suhasna Maithili
000228392 909C0 $$0252196$$pLMRP$$xU11032
000228392 909C0 $$0252085$$pTTO$$xU10021
000228392 917Z8 $$x148230
000228392 937__ $$aEPFL-PATENT-228392
000228392 973__ $$aEPFL
000228392 980__ $$aPATENT